|
1
|
Pantalone KM and Faiman C: Male
hypogonadism: More than just a low testosterone. Cleve Clin J Med.
79:717–725. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang C and Swerdloff R: Definition of male
hypogonadism. 2011.
|
|
3
|
Melman A and Gingell JC: The epidemiology
and pathophysiology of erectile dysfunction. J Urol. 161:5–11.
1999.PubMed/NCBI
|
|
4
|
Hijazi RA and Cunningham GR: Andropause:
Is androgen replacement therapy indicated for the aging male? Annu
Rev Med. 56:117–137. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bhasin S, Cunningham GR, Hayes FJ,
Matsumoto AM, Snyder PJ, Swerdloff RS and Montori VM: Testosterone
therapy in adult men with androgen deficiency syndromes: An
endocrine society clinical practice guideline. J Clin Endocrinol
Metab. 91:1995–2010. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rey RA, Grinspon R, Gottlieb S, Pasqualini
T, Knoblovits P, Aszpis S, Pacenza N, Stewart Usher J, Bergadá I
and Campo SM: Male hypogonadism: An extended classification based
on a developmental, endocrine physiology-based approach. Andrology.
1:3–16. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Arnaud L, Nordin A, Lundholm H,
Svenungsson E, Hellbacher E, Wikner J, Zickert A and Gunnarsson I:
Effect of corticosteroids and cyclophosphamide on sex hormone
profiles in male patients with systemic lupus erythematosus or
systemic sclerosis. Arthritis Rheumatol. 69:1272–1279.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Mager DE, Lin SX, Blum RA, Lates CD and
Jusko WJ: Dose equivalency evaluation of major corticosteroids:
Pharmacokinetics and cell trafficking and cortisol dynamics. J Clin
Pharmacol. 43:1216–1227. 2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
MacAdams MR, White RH and Chipps BE:
Reduction of serum testosterone levels during chronic
glucocorticoid therapy. Ann Intern Med. 104:648–651.
1986.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Moghadam-Kia S and Werth VP: Prevention
and treatment of systemic glucocorticoid side effects. Int J
Dermatol. 49:239–248. 2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Whirledge S and Cidlowski JA:
Glucocorticoids, stress, and fertility. Minerva Endocrinol.
35:109–125. 2010.PubMed/NCBI
|
|
12
|
Yazawa H, Sasagawa I and Nakada T:
Apoptosis of testicular germ cells induced by exogenous
glucocorticoid in rats. Hum Reprod. 15:1917–1920. 2000.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Crawford BA, Liu PY, Kean MT, Bleasel JF
and Handelsman DJ: Randomized placebo-controlled trial of androgen
effects on muscle and bone in men requiring long-term systemic
glucocorticoid treatment. J Clin Endocrinol Metab. 88:3167–3176.
2003.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Costello R, Patel R, Humphreys J, McBeth J
and Dixon WG: Timing of glucocorticoid administration: A
cross-sectional survey of glucocorticoid users in an online social
network for health. Rheumatology (Oxford, England). 56:494–495.
2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Woolf PD, Hamill RW, Mcdonald JV, Lee LA
and Kelly M: Transient hypogonadotropic hypogonadism caused by
critical illness. J Clin Endocrinol Metab. 60:444–450.
1985.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Woolf P, Hamill R, McDonald J, Lee LA and
Kelly M: Transient hypogonadotrophic hypogonadism after head
trauma: Effects on steroid precursors and correlation with
sympathetic nervous system activity. Clin Endocrinol (Oxf).
25:265–274. 1986.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Morrison D, Capewell S, Reynolds S, Thomas
J, Ali N, Read G, Henley R and Riad-Fahmy D: Testosterone levels
during systemic and inhaled corticosteroid therapy. Respir Med.
88:659–663. 1994.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Contreras LN, Masini AM, Danna MM, Kral M,
Bruno OD, Rossi MA and Andrada JA: Glucocorticoids: Their role on
gonadal function and LH secretion. Minerva Endocrinol. 43–46.
1996.PubMed/NCBI
|
|
19
|
Tengstrand B, Carlström K and Hafström I:
Bioavailable testosterone in men with rheumatoid arthritis-high
frequency of hypogonadism. Rheumatology (Oxford). 41:285–289.
2002.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tan RS, Cook KR and Reilly WG: High
estrogen in men after injectable testosterone therapy: The low T
experience. Am J Mens Health. 9:229–234. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lee JK and Imperato-McGinley J: Estrogen
and the male. 2004.
|
|
22
|
Gong H, Jarzynka MJ, Cole TJ, Lee JH, Wada
T, Zhang B, Gao J, Song WC, DeFranco DB, Cheng SY and Xie W:
Glucocorticoids antagonize estrogens by glucocorticoid
receptor-mediated activation of estrogen sulfotransferase. Cancer
Res. 68:7386–7393. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Martens H, Sheets P, Tenover J, Dugowson
C, Bremner W and Starkebaum G: Decreased testosterone levels in men
with rheumatoid arthritis: Effect of low dose prednisone therapy. J
Rheumatol. 21:1427–1431. 1994.PubMed/NCBI
|
|
24
|
He Y, Yi W, Suino-Powell K, Zhou XE,
Tolbert WD, Tang X, Yang J, Yang H, Shi J, Hou L, et al: Structures
and mechanism for the design of highly potent glucocorticoids. Cell
Res. 24:713–726. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Steven K: Adrenal cortical steroids. Drug
facts and comparisons 5th ed St Louis: Facts and Comparisons, Inc.
pp.122-128, 1997.
|
